Interview with Ulrich Eggert, Managing Director, Astellas Pharma Germany
Astellas has been present in the German market for almost two decades through Yamanouchi and Fujisawa. But since 2005 it gained a new identity thanks to the merger of the…
Address: Am Klopferspitz 19a, 82152 Martinsried,Germany
Tel: +49 (0) 89 700760 283
CRELUX provides fast and affordable access to co-crystal structures of compounds in complex with their protein targets. As an integrated protein service provider the company also delivers batches of ultra pure protein certified for use in crystallization or assays. Crystallization conditions of numerous relevant therapeutic targets have been established at CRELUX. Co-crystal structures of these targets in complex with compounds of interest to clients are delivered at a fixed price with a typical turn around time of only a few months.
Astellas has been present in the German market for almost two decades through Yamanouchi and Fujisawa. But since 2005 it gained a new identity thanks to the merger of the…
Cytonet is today Germany’s largest cell therapy enterprise. However, it went through many transformations since its spin-off from Roche Diagnostics in 2000. Could you briefly introduce the company to our…
The German Pharmaceutical Industry is not only known for its cutting-edge R&D and production base but also for having a high penetration of generics. In your opinion, what role do…
You have a wide experience in the pharmaceutical industry having worked for companies such as Amgen and Servier. What attracted you to Basilea? When I first considered moving to Basilea…
When we met Dr. Aleiotti in Italy, he said how important was Menarini´s acquisition of Berlin Chemie in the 1990s for the internationalization of the company in Eastern Europe and…
See our Cookie Privacy Policy Here
